On back of attending ChannelAdvisor’s Catalyst 2017 annual user conference in Nasvhille on March 7th and 8th, William Blair analyst Ryan Domyancic has …
Ocera Therapeutics Inc (NASDAQ:OCRX) and Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) are soaring up, up, and away into the biotech-verse stratosphere today, and Aegis and …
Analysts from Morgan Stanley and Needham are sharing their two cents on Tesla Inc (NASDAQ:TSLA) and NVIDIA Corporation (NASDAQ:NVDA). One analyst is positive …
Maxim analyst Jason Kolbert is optimistic on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) on the heels of the biotech firm indicating that the Pediatric …
Between NVIDIA Corporation (NASDAQ:NVDA) and its stellar market advantage as well as Apple Inc. (NASDAQ:AAPL) shares soaring ahead of the iPhone X release, …
As BMO delves closer into Apple Inc. (NASDAQ:AAPL) and its iPhone installed base while Barclays sings the praises of the recent preannouncement from …
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares have been skyrocketing following the biotech firm’s major success with its Phase IIb trial evaluating voclosporin (VCS) …
Karyopharm Therapeutics Inc (NASDAQ:KPTI) shares are falling 16% after the biotech firm’s Phase 2 trial evaluating Selinexor in Older Patients with Relapsed Acute …
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) shares are currently rising almost 8% after the biotech firm released the rare, good news that its drug in …
Synthetic Biologics Inc (NYSEMKT:SYN) is steaming right along with key programs gearing toward pivotal studies. Despite financing continuing to be the real stand-out …
